FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080168197> ?p ?o ?g. }

• W3080168197 endingPage "7770" @default.
• W3080168197 startingPage "7761" @default.
• W3080168197 abstract "To develop novel models for predicting extracapsular extension (EPE), seminal vesicle invasion (SVI), or upgrading in prostate cancer (PCa) patients using clinical parameters, biparametric magnetic resonance imaging (bp-MRI), and transrectal ultrasonography (TRUS)-guided systematic biopsies.We retrospectively collected data from PCa patients who underwent standard (12-core) systematic biopsy and radical prostatectomy. To develop predictive models, the following variables were included in multivariable logistic regression analyses: total prostate-specific antigen (TPSA), central transition zone volume (CTZV), prostate-specific antigen (PSAD), maximum diameter of the index lesion at bp-MRI, EPE at bp-MRI, SVI at bp-MRI, biopsy Gleason grade group, and number of positive biopsy cores. Three risk calculators were built based on the coefficients of the logit function. The area under the curve (AUC) was applied to determine the models with the highest discrimination. Decision curve analyses (DCAs) were performed to evaluate the net benefit of each risk calculator.A total of 222 patients were included in this study. Overall, 83 (37.4%), 75 (33.8%), and 107 (48.2%) patients had EPE, SVI, and upgrading at final pathology, respectively. The addition of bp-MRI data improved the discrimination of models for predicting SVI (0.807 vs 0.816) and upgrading (0.548 vs 0.625) but not EPE (0.766 vs 0.763). Similarly, models including clinical parameters, bp-MRI data, and information on systematic biopsies achieved the highest AUC in the prediction of EPE (0.842), SVI (0.913), and upgrading (0.794), and the three corresponding risk calculators yielded the highest net benefit.We developed three easy-to-use risk calculators for the prediction of adverse pathological features based on patient clinical parameters, bp-MRI data, and information on systematic biopsies. This may be greatly beneficial to urologists in the decision-making process for PCa patients." @default.
• W3080168197 created "2020-09-01" @default.
• W3080168197 creator A5000923634 @default.
• W3080168197 creator A5005724675 @default.
• W3080168197 creator A5009276949 @default.
• W3080168197 creator A5020575647 @default.
• W3080168197 creator A5030950854 @default.
• W3080168197 creator A5039671349 @default.
• W3080168197 creator A5058780708 @default.
• W3080168197 creator A5072211574 @default.
• W3080168197 creator A5086664647 @default.
• W3080168197 date "2020-08-01" @default.
• W3080168197 modified "2023-10-17" @default.
• W3080168197 title "<p>Added Value of Biparametric MRI and TRUS-Guided Systematic Biopsies to Clinical Parameters in Predicting Adverse Pathology in Prostate Cancer</p>" @default.
• W3080168197 cites W1494521255 @default.
• W3080168197 cites W1499310009 @default.
• W3080168197 cites W1545430154 @default.
• W3080168197 cites W1827911007 @default.
• W3080168197 cites W1980514128 @default.
• W3080168197 cites W2135487780 @default.
• W3080168197 cites W2162716125 @default.
• W3080168197 cites W2166339706 @default.
• W3080168197 cites W2170422241 @default.
• W3080168197 cites W2272984102 @default.
• W3080168197 cites W2401968708 @default.
• W3080168197 cites W2461950892 @default.
• W3080168197 cites W2511791204 @default.
• W3080168197 cites W2768064542 @default.
• W3080168197 cites W2782047998 @default.
• W3080168197 cites W2793905111 @default.
• W3080168197 cites W2799837109 @default.
• W3080168197 cites W2805153607 @default.
• W3080168197 cites W2806074598 @default.
• W3080168197 cites W2885929244 @default.
• W3080168197 cites W2895926103 @default.
• W3080168197 cites W2896430583 @default.
• W3080168197 cites W2902806174 @default.
• W3080168197 cites W2911188335 @default.
• W3080168197 cites W2940128147 @default.
• W3080168197 cites W2947469118 @default.
• W3080168197 cites W2968267652 @default.
• W3080168197 cites W2972283839 @default.
• W3080168197 cites W2973334574 @default.
• W3080168197 cites W2995275609 @default.
• W3080168197 cites W3010132437 @default.
• W3080168197 doi "https://doi.org/10.2147/cmar.s260986" @default.
• W3080168197 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7457849" @default.
• W3080168197 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32922077" @default.
• W3080168197 hasPublicationYear "2020" @default.
• W3080168197 type Work @default.
• W3080168197 sameAs 3080168197 @default.
• W3080168197 citedByCount "2" @default.
• W3080168197 countsByYear W30801681972022 @default.
• W3080168197 countsByYear W30801681972023 @default.
• W3080168197 crossrefType "journal-article" @default.
• W3080168197 hasAuthorship W3080168197A5000923634 @default.
• W3080168197 hasAuthorship W3080168197A5005724675 @default.
• W3080168197 hasAuthorship W3080168197A5009276949 @default.
• W3080168197 hasAuthorship W3080168197A5020575647 @default.
• W3080168197 hasAuthorship W3080168197A5030950854 @default.
• W3080168197 hasAuthorship W3080168197A5039671349 @default.
• W3080168197 hasAuthorship W3080168197A5058780708 @default.
• W3080168197 hasAuthorship W3080168197A5072211574 @default.
• W3080168197 hasAuthorship W3080168197A5086664647 @default.
• W3080168197 hasBestOaLocation W30801681971 @default.
• W3080168197 hasConcept C121608353 @default.
• W3080168197 hasConcept C126322002 @default.
• W3080168197 hasConcept C126838900 @default.
• W3080168197 hasConcept C126894567 @default.
• W3080168197 hasConcept C143409427 @default.
• W3080168197 hasConcept C151956035 @default.
• W3080168197 hasConcept C2775934546 @default.
• W3080168197 hasConcept C2776235491 @default.
• W3080168197 hasConcept C2779466945 @default.
• W3080168197 hasConcept C2780002838 @default.
• W3080168197 hasConcept C2780192828 @default.
• W3080168197 hasConcept C2781217009 @default.
• W3080168197 hasConcept C2781406297 @default.
• W3080168197 hasConcept C58471807 @default.
• W3080168197 hasConcept C71924100 @default.
• W3080168197 hasConcept C76318530 @default.
• W3080168197 hasConceptScore W3080168197C121608353 @default.
• W3080168197 hasConceptScore W3080168197C126322002 @default.
• W3080168197 hasConceptScore W3080168197C126838900 @default.
• W3080168197 hasConceptScore W3080168197C126894567 @default.
• W3080168197 hasConceptScore W3080168197C143409427 @default.
• W3080168197 hasConceptScore W3080168197C151956035 @default.
• W3080168197 hasConceptScore W3080168197C2775934546 @default.
• W3080168197 hasConceptScore W3080168197C2776235491 @default.
• W3080168197 hasConceptScore W3080168197C2779466945 @default.
• W3080168197 hasConceptScore W3080168197C2780002838 @default.
• W3080168197 hasConceptScore W3080168197C2780192828 @default.
• W3080168197 hasConceptScore W3080168197C2781217009 @default.
• W3080168197 hasConceptScore W3080168197C2781406297 @default.
• W3080168197 hasConceptScore W3080168197C58471807 @default.
• W3080168197 hasConceptScore W3080168197C71924100 @default.
• W3080168197 hasConceptScore W3080168197C76318530 @default.
• W3080168197 hasLocation W30801681971 @default.

• next